Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Anemia

Free Subscription Articles published in Hemoglobin Retrieve available abstracts of 132 articles: HTML format

Single Articles

July 2025
1. MARHATTA A, Choudhuri J, Mulvey JJ, Campbell S, et al
   When Unstable Hemoglobin Lansing Interacts with Alpha Thalassemia Along with HbS: An Interesting Case with Unique Clinical Presentation.
   Hemoglobin. 2025;49:305-308.
   PubMed     Abstract available
   
   
   
2. MUANGPA S, Jermnim S, Charoenporn P, Suannum P, et al
   Detection of Common alpha-Hemoglobin Variants in Thailand by Using Real-Time PCR with High Resolution Melting Analysis.
   Hemoglobin. 2025;49:257-267.
   PubMed     Abstract available
   
   
   
3. LI W, Wei G, Ren S, Xie Z, et al
   HBA2: C.4delG: A Novel Frameshift Mutation Causing alpha(+)-Thalassemia Found in a Chinese Family.
   Hemoglobin. 2025;49:301-304.
   PubMed     Abstract available
   
   
   
4. LIU P, Wang J, Luo H, Tang XW, et al
   A Novel Large Deletion Including the Major Regulatory Element Compounded with SEA Deletion Causing Hydrops-Fetalis-Syndrome.
   Hemoglobin. 2025;49:289-293.
   PubMed     Abstract available
   
   
   
5. YE L, Li W, Wei G, Shen X, et al
   Misdiagnosis of alpha-Thalassemia Heterozygotes as Homozygotes Due to Base Mutations in the Primer Binding Region.
   Hemoglobin. 2025;49:237-243.
   PubMed     Abstract available
   
   
   
6. AMINI MA, Afgar A, Daneshi Cohan S, Soleimani S, et al
   Association of Micro RNA-155 with Alloimmunization in Transfusion-Dependent Thalassemia Patients.
   Hemoglobin. 2025;49:268-274.
   PubMed     Abstract available
   
   
   
7. HUANG X, Shi L, Lai Y, Li J, et al
   KLF1 Knockdown Differentially Regulates gamma-Globin Expression: Inhibition in K562 Cells but Reactivation in beta-Thalassemia Major Erythrocytes with Erythropoiesis Disruption.
   Hemoglobin. 2025;49:244-251.
   PubMed     Abstract available
   
   
   
8. OGGIONNI M, Manenti B
   Hereditary Persistence of Fetal Hemoglobin (HPFH): Detection of Unknow (A)gamma-Globin Promoter Mutation at the C2H2 Zinc Finger Transcription Factors Binding Sites.
   Hemoglobin. 2025;49:298-300.
   PubMed     Abstract available
   
   
   May 2025
9. DIXIT A, Hegde A, M S R
   Clinical Implications of HbD-Punjab and HbS co-Inheritance - A Rare Case in South India.
   Hemoglobin. 2025;49:208-212.
   PubMed     Abstract available
   
   
   
10. SHAMOON M, Mahmood R, Bozdar M, Yousof S, et al
    Unraveling Hemoglobin D's Influence: A Comprehensive Analysis of Clinicopathological Parameters in Hemoglobin D Patients.
    Hemoglobin. 2025;49:195-199.
    PubMed     Abstract available
    
    
    
11. RUENGDIT C, Punyamung M, Maneewong K, Khamphikham P, et al
    Characterization of HbH Disease Caused by Compound Heterozygotes alpha(+)-Thalassemia 3.7 kb Deletion and a Large Novel alpha(0)-Thalassemia Deletion.
    Hemoglobin. 2025;49:229-232.
    PubMed     Abstract available
    
    
    
12. AKBARNATAJ H, Eghbali A, Ashayeri N, Padooiy Nooshabadi M, et al
    Evaluating Renal Glomerular Function in Beta-Thalassemia Patients Receiving Deferasirox Using Serum Cystatin-C and Creatinine: A Cross-Sectional Study.
    Hemoglobin. 2025;49:178-186.
    PubMed     Abstract available
    
    
    
13. TIWARI A, Rao E, Suresh I, Tiwari M, et al
    Hepatobiliary Manifestations in Thalassemia Patients: A Narrative Review.
    Hemoglobin. 2025;49:200-207.
    PubMed     Abstract available
    
    
    
14. JAJODIA E, Arora N, Haque M, Ganguly T, et al
    Heterozygous Beta Thalassemia with Segmental Duplication of chr16p13.3 Leading to Thalassemia Intermedia Phenotype: A Report of 2 Cases with Review of Literature.
    Hemoglobin. 2025;49:222-228.
    PubMed     Abstract available
    
    
    
15. RODRIGUEZ DE LA CRUZ NJ, Mengana Torres Y, Garcia Naranjo JC, Ricardo Ferro BT, et al
    Dynamic Viscosity of Hemoglobin Solutions Determined by Transverse Proton Magnetic Relaxation.
    Hemoglobin. 2025;49:172-177.
    PubMed     Abstract available
    
    
    
16. RAMSAY Z, Sharma D, Wisdom-Phipps M, Chin N, et al
    Estradiol is Pro-Nociceptive and Associated with a Small-Fiber Neuropathy Among Premenopausal Women with Sickle Cell Disease.
    Hemoglobin. 2025;49:161-171.
    PubMed     Abstract available
    
    
    
17. COOMER CA, Levin RA, Neri CM
    Death from S. pneumoniae in HbSC Disease: Was Expanded Pneumococcal Vaccination Too Late?
    Hemoglobin. 2025;49:213-217.
    PubMed     Abstract available
    
    
    March 2025
18. USSHER FA, Laing EF, Kontor EK, Atta-Owusu AB, et al
    Haplotype-Specific Genetic Epidemiology of Sickle Cell Anemia Patients in Accra, Ghana: Patterns, Clinical Implications, and Public Health Responses.
    Hemoglobin. 2025 Mar 5:1-9. doi: 10.1080/03630269.2025.2474609.
    PubMed     Abstract available
    
    
    
19. FORTE S, Couette M, Oudin Doglioni D, Desmarais P, et al
    Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: A Bilingual Multisite Observational Study.
    Hemoglobin. 2025;49:156-159.
    PubMed     Abstract available
    
    
    
20. HUANG YY, Ye LH, Li W, Wei GX, et al
    Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern China.
    Hemoglobin. 2025;49:94-102.
    PubMed     Abstract available
    
    
    
21. NIK MOHD HASAN NFF, Achour A, Koopmann T, Gammeren AV, et al
    Unusual Causes of beta Thalassemia Trait: Discovery of another Three Novel SUPT5H Variants.
    Hemoglobin. 2025;49:145-148.
    PubMed     Abstract available
    
    
    
22. XU Y, Luo H, Huang T, Fang Y, et al
    Molecular Characterization of Complex Thalassemia with Multiple Variants in beta-Globin Gene Cluster and the Identification of a Novel Structural Rearrangement in gamma-Globin Gene.
    Hemoglobin. 2025;49:149-152.
    PubMed     Abstract available
    
    
    
23. JOMOUI W, Tepakhan W
    Rapid and Visual Molecular Detection of High Hb F Determinants; HPFH6, Asian Indian inv-del ((A)gammadeltabeta)(0)-Thalassemia, and Thai del-inv-ins ((A)gammadeltabeta)(0)-Thalassemia Using LAMP Colorimetric Phenol Red Assays.
    Hemoglobin. 2025;49:103-110.
    PubMed     Abstract available
    
    
    
24. BAZI A, Khanahmad A, Khazaee-Nasirabadi MH, Pirouzbakht M, et al
    Long-Term and Transient Calcium Channel Blockers; A Systematic Review of Their Role in the Management of Cardiomyopathy in Transfusion-Dependent Thalassemia.
    Hemoglobin. 2025;49:111-125.
    PubMed     Abstract available
    
    
    
25. AL-ALLAWI N, Al-Mousawi MM, Al Allawi S, Ibrahim KJ, et al
    Alloimmunization in beta-Thalassemia and Sickle Cell Disease in Middle Eastern Countries: A Systemic Review.
    Hemoglobin. 2025;49:126-140.
    PubMed     Abstract available
    
    
    
26. MISHRA V, Singh Yadav P, Singh R, Rainchwar S, et al
    Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.
    Hemoglobin. 2025;49:78-84.
    PubMed     Abstract available
    
    
    
27. RODCHAPROM P, Fanhchaksai K, Maneekesorn S, Kittisakmontri K, et al
    Prevalence and Associated Factors of Zinc and Vitamin D Deficiencies in Pediatric and Young Adult Patients with Non-Transfusion-Dependent Thalassemia.
    Hemoglobin. 2025;49:73-77.
    PubMed     Abstract available
    
    
    January 2025
28. WINGER BA, Ajayi A, Vichinsky E
    Diagnosis and Treatment of Alpha Thalassemia Major.
    Hemoglobin. 2025;49:3-9.
    PubMed     Abstract available
    
    
    
29. HAMBLETON I, Mason K, Serjeant B, Serjeant G, et al
    Hypersplenism Affects Growth and Haematology in HbSS: Observations from the Jamaican Birth Cohort.
    Hemoglobin. 2025;49:47-53.
    PubMed     Abstract available
    
    
    
30. ALOOFY TA, Aleem A, Algahtani FH, Al-Shehri A, et al
    Long-Term Survival Rates of a Sickle Cell Disease Cohort in Saudi Arabia: A 2009-2023 Observational Study.
    Hemoglobin. 2025;49:54-59.
    PubMed     Abstract available
    
    
    
31. TEPAKHAN W, Attakan N, Kanjanaopas S, Srewaradachpisal K, et al
    Rapid Identification of beta-Thalassemia, Hb E, and High Hb F Determinants Using a High-Resolution Melting Analysis: Application in Prenatal Diagnosis in Southern Thailand.
    Hemoglobin. 2025;49:38-46.
    PubMed     Abstract available
    
    
    
32. TANG B, Chen K, Liang L, Li J, et al
    Characterization and Confirmation of Mildly Unstable Hb Pontoise or alpha1 63(E12) Ala > Asp and Literature Review.
    Hemoglobin. 2025;49:26-30.
    PubMed     Abstract available
    
    
    
33. SUALI L, Mohammad Salih FA, Ibrahim MY, Bin Jeffree MS, et al
    The Effect of Single Nucleotide Polymorphisms on Clinical Phenotypes of Sabahan Transfusion-Dependent beta-Thalassemia Patients with Homozygous Filipino beta(0)-Deletion.
    Hemoglobin. 2025;49:10-19.
    PubMed     Abstract available
    
    
    
34. ZENG GK, Yang YF, Ge YY, Yang Y, et al
    Identification of a beta-Globin Gene Mutation with the Genotype beta-28(A > G), IVS-I-5(G > A)/betaCD 71/72(+A) Using Third-Generation Sequencing.
    Hemoglobin. 2025;49:63-68.
    PubMed     Abstract available
    
    
    
35. HASSAN MK, Abbas RA, Hassan RA, Taghlubee IM, et al
    Prevalence and Spectrum of beta-Thalassemia Mutations in Baghdad, Iraq: Data from the Premarital Screening Program.
    Hemoglobin. 2025;49:31-37.
    PubMed     Abstract available
    
    
    
36. SEGUNMARU Z, Bayo F, Tobias AJ, Wingate LT, et al
    Knowledge of Sickle Cell Disease, Awareness of Sickle Cell Trait Status and Its Impact on Relationships Among Students at a Historically Black College.
    Hemoglobin. 2025;49:20-25.
    PubMed     Abstract available
    
    
    
37. ZHOU JY, Wang CY, Li J, Chen GL, et al
    First Reported Case of Hemoglobin H Disease Caused by the Rare alpha-Globin Gene Mutation (HBA2 c.244delT) in a Chinese Family.
    Hemoglobin. 2025;49:69-71.
    PubMed     Abstract available
    
    
    December 2024
38. MAKALO L, Adegoke SA, Allen SJ, Kuti BP, et al
    Sociodemographic and Clinical Factors Predictive of Poor Health-Related Quality of Life of Children with Sickle Cell Anemia in The Gambia.
    Hemoglobin. 2024 Dec 18:1-9. doi: 10.1080/03630269.2024.2440030.
    PubMed     Abstract available
    
    
    November 2024
39. DRYLLIS G, Russo R, Andolfo I, Iolascon A, et al
    Hereditary Hemolytic Anemia Due to PIEZO1 Red Blood Cell Membrane Defect.
    Hemoglobin. 2024 Nov 26:1-3. doi: 10.1080/03630269.2024.2427187.
    PubMed     Abstract available
    
    
    
40. NING S, Qin Y, Xie Y, Liang Y, et al
    The First Compound Heterozygosity for Two Different alpha-Thalassemia Determinants Causes Hb Bart's Hydrops Fetalis in a Chinese Family.
    Hemoglobin. 2024;48:384-388.
    PubMed     Abstract available
    
    
    
41. TAN L, Huang T, Luo L, Ma P, et al
    Molecular Identification and the Hematological Findings of Four Novel Variants in Globin Genes in Jiangxi Province of Southern China.
    Hemoglobin. 2024;48:369-374.
    PubMed     Abstract available
    
    
    
42. ASKARIAN-SARDARI F, Esmaeilian S, Hajimohammadi Z, Hayat-Nosaeid M, et al
    The Most Common Types of 3.7 Kilobase Deletion in the Iranian Population.
    Hemoglobin. 2024;48:365-368.
    PubMed     Abstract available
    
    
    September 2024
43. YE LH, Huang YY, Zhu ZT, Jiang AQ, et al
    alpha(0)-Thalassemia Caused by a Novel alpha-Globin Gene Cluster Deletion (-(LB)) Found in a Chinese Family.
    Hemoglobin. 2024;48:341-345.
    PubMed     Abstract available
    
    
    
44. KARNPEAN R, Tepakhan W, Rungruang K, Pongpatchara P, et al
    The Validation of Whole beta-Globin Gene Sequencing for Detecting beta-Thalassemia Mutations Found in Thailand Using Next-Generation Sequencing (NGS).
    Hemoglobin. 2024;48:333-340.
    PubMed     Abstract available
    
    
    
45. MAMMADOVA T, Asadov C, Alimirzoyeva Z, Abdulalimov E, et al
    Update on Prevention of Hemoglobinopathies in Azerbaijan.
    Hemoglobin. 2024;48:353-356.
    PubMed     Abstract available
    
    
    
46. LIANG JL, Ge YY, Xie LX, Zeng GK, et al
    Phenotypic Analysis of the HBA2: C.95 G > A Mutation in China.
    Hemoglobin. 2024;48:329-332.
    PubMed     Abstract available
    
    
    
47. ROMADHON PZ, Ashariati A, Bintoro SUY, Suryantoro SD, et al
    Existing Tubular Injury in beta-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia.
    Hemoglobin. 2024;48:301-307.
    PubMed     Abstract available
    
    
    
48. GUINDO A, Koya A, Sarro YDS, Toure AB, et al
    Analysis of Iron Status in Sickle Cell Disease Patients During Steady State at the Center de Recherche et de Lutte contre la Drepanocytose (CRLD) Bamako.
    Hemoglobin. 2024;48:314-318.
    PubMed     Abstract available
    
    
    
49. ABBAS RA, Hassan RH, Taghlubee IM, Mohammed SI, et al
    Prevalence and Molecular Characterization of beta-Thalassemia in Kirkuk Province of Northern Iraq.
    Hemoglobin. 2024;48:308-313.
    PubMed     Abstract available
    
    
    
50. GIUBBILEI C, D'Angelo S, Fotzi I, Mogni M, et al
    deltabeta-Thalassemia and alpha-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?
    Hemoglobin. 2024;48:349-352.
    PubMed     Abstract available
    
    
    July 2024
51. RASLAN IA, Solh Z, Kuo KHM, Abdulrehman J, et al
    Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Hemoglobin. 2024;48:231-243.
    PubMed     Abstract available
    
    
    
52. TAVASSOLI S, Chung JH, Panigrahi AR, Shahsavar A, et al
    Hemoglobin Balkh, a Novel Mutation in Codon 132 of alpha2-Globin Gene [alpha132(H15) (+T) or HBA2:C.396dup (p.Val134fs)]: A Case Report and Insight into the Pathophysiology.
    Hemoglobin. 2024;48:280-284.
    PubMed     Abstract available
    
    
    
53. YALCIN N, Sadri S, Ertinmaz Ozkan A, Gursoy V, et al
    Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia.
    Hemoglobin. 2024;48:292-300.
    PubMed     Abstract available
    
    
    
54. SERJEANT BE, Mason K, Reid M, Hambleton I, et al
    The Aplastic Crisis in HbSS: Observations from the Jamaican Birth Cohort.
    Hemoglobin. 2024;48:274-279.
    PubMed     Abstract available
    
    
    
55. POH KY, Bee PC
    First Report of Hb Youngstown in Capillary Electrophoresis and Overlapping Hb Analysis Findings with Hb Rush.
    Hemoglobin. 2024;48:254-257.
    PubMed     Abstract available
    
    
    
56. SONGDEJ D, Kadegasem P, Sirachainan N, Ruengdit C, et al
    The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for alpha-Thalassemia-1 Chiang Rai (--(CR)) Type Deletion with Hb Constant Spring.
    Hemoglobin. 2024;48:261-264.
    PubMed     Abstract available
    
    
    
57. COSKUN C, Unal S
    Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country.
    Hemoglobin. 2024;48:258-260.
    PubMed     Abstract available
    
    
    
58. KEITA M, Seck M, Diallo AB, Toure SA, et al
    Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.
    Hemoglobin. 2024;48:285-291.
    PubMed     Abstract available
    
    
    
59. JIANG F, Huang S, Liu T, Wang J, et al
    Identification of a Novel 16.8Kb Deletion of the alpha-Globin Gene Cluster by Third-Generation Sequencing.
    Hemoglobin. 2024;48:244-249.
    PubMed     Abstract available
    
    
    
60. DA SILVA ARAUJO A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, et al
    Sickle Cell Disease in Brazil: Current Management.
    Hemoglobin. 2024;48:218-230.
    PubMed     Abstract available
    
    
    June 2024
61. CHIGUER A, Lyahyai J, El Kadiri Y, Cherkaoui Jaouad I, et al
    Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia.
    Hemoglobin. 2024 Jun 4:1-4. doi: 10.1080/03630269.2024.2360456.
    PubMed     Abstract available
    
    
    May 2024
62. RAO E, Patel D, Saxena N, Saha KB, et al
    Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint.
    Hemoglobin. 2024;48:212-213.
    PubMed    
    
    
    
63. ASRI AS, Samsuddin MH, Jalil N, Mohamad Tahir N, et al
    Characterization of Hemoglobin Malay Phenotypes in Tertiary Hospitals.
    Hemoglobin. 2024;48:153-160.
    PubMed     Abstract available
    
    
    
64. SINGH R, Halder R, Hemant Gupta V, Rainchwar S, et al
    ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.
    Hemoglobin. 2024;48:186-191.
    PubMed     Abstract available
    
    
    
65. YAO C, Chen L, Ma J, Li N, et al
    A Novel Frameshift Mutation of HBB Causing Dominant beta-Thalassemia in a Chinese Individual.
    Hemoglobin. 2024;48:182-185.
    PubMed     Abstract available
    
    
    
66. BHATTACHARJEE S, Ghosh S, Shaw J, Bhattacharjee S, et al
    Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.
    Hemoglobin. 2024;48:161-168.
    PubMed     Abstract available
    
    
    
67. ADEGOKE SA, Makalo L, Sallah A, Saine H, et al
    Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Hemoglobin. 2024;48:169-174.
    PubMed     Abstract available
    
    
    
68. RAVICHANDRAN S, Hoffmann M, Petersen J, Sjo L, et al
    A Rare Case of De Novo Beta-Thalassemia Diagnosed by Whole-Genome Sequencing in an Ethnically Danish Newborn.
    Hemoglobin. 2024;48:196-199.
    PubMed     Abstract available
    
    
    
69. IBRAHIM L, Gwarzo DH, Yusuf AA
    Secretory Phospholipase A2 Levels Are High in Women with Sickle Cell Disease and Menstruation-Induced Vaso-Occlusive Crises.
    Hemoglobin. 2024;48:175-181.
    PubMed     Abstract available
    
    
    
70. HE X, Tian P, Zhong L, Peng S, et al
    A Novel 165 Kb Duplication Involving the alpha-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient.
    Hemoglobin. 2024;48:203-208.
    PubMed     Abstract available
    
    
    
71. PAN L, Wang Y, Lin H, Zhang X, et al
    A Novel Frameshift Mutation(HBA2:C.337delC) Associated With alpha-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2024;48:200-202.
    PubMed     Abstract available
    
    
    April 2024
72. KUMARI A, Chauhan G, Chaudhuri PK, Kumari S, et al
    Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis.
    Hemoglobin. 2024 Apr 18:1-12. doi: 10.1080/03630269.2024.2340685.
    PubMed     Abstract available
    
    
    March 2024
73. LIU D, Nong X, Lai F, Nong C, et al
    Noninvasive Prenatal Diagnosis of SEA-Thalassemia by Combining 1000 Genomes Database and Relative Haplotype Dosage.
    Hemoglobin. 2024;48:71-78.
    PubMed     Abstract available
    
    
    
74. VOUSVOUKI M, Delaki EE, Boutou E, Yfanti E, et al
    A New alpha1-Globin Variant, Hb Ormylia [HBA1:c.63C > G; p.His21Gln]. Report of Eleven Cases in Northern Greece.
    Hemoglobin. 2024;48:133-137.
    PubMed     Abstract available
    
    
    
75. ASSAF N, El Zibaoui R, Monsef C, Abi Nassif T, et al
    Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two alpha-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.
    Hemoglobin. 2024;48:129-132.
    PubMed     Abstract available
    
    
    
76. CHIN N, Asnani M
    Poor Sleep Quality in Jamaican Adults With Sickle Cell Disease: Prevalence, Risk Factors, and Association With Quality of Life.
    Hemoglobin. 2024;48:87-93.
    PubMed     Abstract available
    
    
    
77. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    Newborn Screening for beta-Thalassemia Identifies a Complex Genotype Involving a Novel beta-Globin Gene Mutation (HBB:c.336dup).
    Hemoglobin. 2024;48:113-115.
    PubMed     Abstract available
    
    
    
78. AL-ALLAWI N, Atroshi SD, Sadullah RK, Eissa AA, et al
    A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With beta-Thalassemia.
    Hemoglobin. 2024;48:94-100.
    PubMed     Abstract available
    
    
    
79. WAYE JS, Hanna M, Nakamura L, Walker L, et al
    Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/beta(0)-Thalassemia.
    Hemoglobin. 2024;48:116-117.
    PubMed     Abstract available
    
    
    February 2024
80. JIANG H, Li DZ
    Early Onset of Severe Anemia Caused by Hb Calgary (HBB: C.194G > T): Another Case Report.
    Hemoglobin. 2024 Feb 12:1-3. doi: 10.1080/03630269.2024.2315188.
    PubMed     Abstract available
    
    
    January 2024
81. KHOSHNAW NSH, Omar JJ, Hussein ZS, Mohammed RN, et al
    Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
    Hemoglobin. 2024;48:56-59.
    PubMed     Abstract available
    
    
    
82. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    beta(0)-Thalassemia Caused by a Novel Nonsense Mutation [HBB:c.199A > T].
    Hemoglobin. 2024;48:69-70.
    PubMed     Abstract available
    
    
    
83. CHUANSUMRIT A, Songdej D, Sirachainan N, Kadegasem P, et al
    Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload.
    Hemoglobin. 2024;48:47-55.
    PubMed     Abstract available
    
    
    
84. DESAI G, Dave K, Devare S, Desai S, et al
    Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease.
    Hemoglobin. 2024;48:66-68.
    PubMed    
    
    
    
85. WU SM, Li C, Huang SR, Jiang F, et al
    A 6-Year Follow-up of a Chinese Child with Homozygous beta(0)-Thalaasemia and a Heterozygous KLF1 Mutation.
    Hemoglobin. 2024;48:60-62.
    PubMed     Abstract available
    
    
    
86. DE OLIVEIRA TAQUES W, Bett GC, de Moraes BLB, Medeiros I, et al
    Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study.
    Hemoglobin. 2024;48:39-46.
    PubMed     Abstract available
    
    
    
87. MAMATA M, Padma G, Pragna Laxmi T, Saroja K, et al
    Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia.
    Hemoglobin. 2024;48:1-3.
    PubMed     Abstract available
    
    
    
88. LADU AI, Kadaura MU, Dauda M, Baba AS, et al
    Malaria Infection in Patients with Sickle Cell Disease in Nigeria: Association with Markers of Hyposplenism.
    Hemoglobin. 2024;48:15-23.
    PubMed     Abstract available
    
    
    
89. ZHENG LH, Liang L, Bai JP, Liao HX, et al
    Misdiagnosis of beta-Thalassemia Major Due to Chinese (G)gamma+((A)gammadeltabeta)(0)-Thalassemia Combined with beta(0)-Thalassemia.
    Hemoglobin. 2024;48:24-29.
    PubMed     Abstract available
    
    
    
90. CHEN M, Lv A, Zhang S, Zheng J, et al
    First Report of Filipino beta(0)-Thalassemia/beta-Thalassemia in a Chinese Family.
    Hemoglobin. 2024;48:34-38.
    PubMed     Abstract available
    
    
    November 2023
91. SILVA BORBOREMA T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R, et al
    Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Hemoglobin. 2023;47:85-96.
    PubMed     Abstract available
    
    
    
92. SAEIDNIA M, Fazeli P, Farzi A, Atefy Nezhad M, et al
    An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
    Hemoglobin. 2023;47:56-70.
    PubMed     Abstract available
    
    
    
93. QIU Y, Wei S, Hou W, Lai K, et al
    Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare beta-Globin Mutations.
    Hemoglobin. 2023;47:52-55.
    PubMed     Abstract available
    
    
    
94. ARAUJO ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, et al
    Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
    Hemoglobin. 2023;47:71-79.
    PubMed     Abstract available
    
    
    
95. TANG HS, Xiong Y, Li DZ
    Fetal Hemoglobin H Hydrops Fetalis: Another Three Case Reports.
    Hemoglobin. 2023;47:102-104.
    PubMed     Abstract available
    
    
    
96. LIU D, Nong C, Lai F, Tang Y, et al
    Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia.
    Hemoglobin. 2023;47:80-84.
    PubMed     Abstract available
    
    
    
97. WU BD, Zhou XY, Xie MJ, Jin CC, et al
    Identification of a Novel 7-bp Deletion in the alpha-Globin Gene Cluster in One Chinese Family.
    Hemoglobin. 2023;47:49-51.
    PubMed     Abstract available
    
    
    
98. LONG J, Gong F, Sun L, Yu C, et al
    A novel alpha Globin Gene Cluster Duplication, alphaalphaalphaalpha(380) Heterozygous beta(0)-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype.
    Hemoglobin. 2023;47:25-30.
    PubMed     Abstract available
    
    
    
99. DEMIDOVA E, Salomashkina V, Selivanova D, Litvin E, et al
    Hb Ryazan: An Elongated C-Terminal beta-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25.
    Hemoglobin. 2023;47:97-101.
    PubMed     Abstract available
    
    
    
100. EGHBALI A, Ghaffari K, Shaykh Baygloo R, Eghbali A, et al
     Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
     Hemoglobin. 2023;47:42-48.
     PubMed     Abstract available
     
     
     
101. SEYDEL GS, Ayan D, Balci T, Bayraktar M, et al
     Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.
     Hemoglobin. 2023;47:36-41.
     PubMed     Abstract available
     
     
     
102. ZHANG W, Han X, Deng J, Zhou R, et al
     Two Novel alpha-Thalassemia Mutations CD 39 -C [Thr > Pro] and CD 109 ACC > CCC [Thr > Pro] Identified in Two Chinese Families: A Case Report.
     Hemoglobin. 2023;47:172-179.
     PubMed     Abstract available
     
     
     
103. XIAO ZQ, Jiang F, Li DZ
     beta-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.
     Hemoglobin. 2023;47:145-146.
     PubMed     Abstract available
     
     
     
104. HAJIMOHAMMADI Z, Alimohammadi-Bidhendi S, Bagheri Amiri F, Karimipoor M, et al
     Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions.
     Hemoglobin. 2023;47:163-166.
     PubMed     Abstract available
     
     
     
105. KHATER D, Al-Mulaabed S, Alomairi A, Elshinawy M, et al
     Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose.
     Hemoglobin. 2023;47:157-162.
     PubMed     Abstract available
     
     
     
106. 'ULYA NM, Indrawati VN, Wulansari WT, Lesmana I, et al
     Mutation Spectrum of beta-Globin Gene in Patients with beta-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
     Hemoglobin. 2023;47:152-156.
     PubMed     Abstract available
     
     
     
107. YILDIRIM AT, Gulen H, Turkmen H, Ozek G, et al
     Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation.
     Hemoglobin. 2023;47:137-139.
     PubMed     Abstract available
     
     
     
108. BAZAZZADEGAN N, Abedini SS, Azarkeivan A, Banihashemi S, et al
     The Spectrum of HBB Mutations among 2315 Beta Thalassemia Patients of a Reference Clinic in Tehran-Iran.
     Hemoglobin. 2023;47:147-151.
     PubMed     Abstract available
     
     
     
109. BABU BV, Sharma Y, Sridevi P, Surti SB, et al
     Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
     Hemoglobin. 2023;47:227-236.
     PubMed     Abstract available
     
     
     
110. HAMALI HA
     Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
     Hemoglobin. 2023;47:205-214.
     PubMed     Abstract available
     
     
     
111. MURAD H, Moassas F, Ali B, Katranji E, et al
     The Spectrum of alpha-Thalassemia Mutations in Syrian Patients.
     Hemoglobin. 2023;47:245-248.
     PubMed     Abstract available
     
     
     
112. KEOWMANI T, Teo SC, Yap KC, Chua WL, et al
     Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study.
     Hemoglobin. 2023;47:237-244.
     PubMed     Abstract available
     
     
     September 2023
113. GREWAL A, Kakkar S, Dewan P, Bansal N, et al
     Prevalence, Severity, and Determinants of Pain in Thalassemia.
     Hemoglobin. 2023;47:191-197.
     PubMed     Abstract available
     
     
     
114. RASHID NW, Al-Allawi N, Tahir HI
     Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease.
     Hemoglobin. 2023;47:198-201.
     PubMed     Abstract available
     
     
     
115. SINGH P, Shaikh S, Parmar S, Gupta R, et al
     Current Status of beta-Thalassemic Burden in India.
     Hemoglobin. 2023;47:181-190.
     PubMed     Abstract available
     
     
     July 2023
116. ABU-ISMAIL L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, et al
     COVID-19 and Anemia: What Do We Know So Far?
     Hemoglobin. 2023 Jul 31:1-8. doi: 10.1080/03630269.2023.2236546.
     PubMed     Abstract available
     
     
     May 2023
117. LIU L, Fu Q, Zhang D, Chen D, et al
     Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
     Hemoglobin. 2023 May 10:1-5. doi: 10.1080/03630269.2023.2206575.
     PubMed     Abstract available
     
     
     
118. AL-ZEBARI S, Al-Allawi NA, Nerweyi F
     Beta Globin Gene Cluster Haplotypes in Beta Thalassemia in the Kurdistan Region of Iraq.
     Hemoglobin. 2023;47:111-117.
     PubMed     Abstract available
     
     
     
119. SHAMOON R, Yassin A, Charkaneh A
     Detection of a Rare Mutation in the Initiation Codon of the beta-Globin Gene (HBB:C.2T > C; P.Met1Thr).
     Hemoglobin. 2023;47:118-121.
     PubMed     Abstract available
     
     
     
120. CHEN YP, Wu P, Wang H, Wu JF, et al
     A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C beta 68(E12) Leu-Pro]: A First Report in the Chinese Population.
     Hemoglobin. 2023;47:130-134.
     PubMed     Abstract available
     
     
     
121. KUMAR R, Ahmad SA, Ozdemir M, Sadayappan S, et al
     Mutation Spectrum of beta-Thalassemia in Some Ethnic Groups of North Maharashtra, India.
     Hemoglobin. 2023;47:105-110.
     PubMed     Abstract available
     
     
     January 2023
122. PUROHIT P, Mohanty PK, Panigrahi J, Das K, et al
     Effect of alpha(+) Thalassemia on the Severity of Plasmodium falciparum Malaria in Different Sickle Cell Genotypes in Indian Adults: A Hospital-Based Study.
     Hemoglobin. 2023;47:11-18.
     PubMed     Abstract available
     
     
     
123. KABIR T, Anwar S, Mourosi JT, Akter S, et al
     alpha- and beta-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh.
     Hemoglobin. 2023;47:3-10.
     PubMed     Abstract available
     
     
     
124. PAN L, Tian P, Chen S, Zhang R, et al
     Novel Promoter Mutation (HBB:C.-139_-138del) Associated with beta-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
     Hemoglobin. 2023;47:21-24.
     PubMed     Abstract available
     
     
     November 2022
125. WEN YJ, Yu QX, Jiang F, Li DZ, et al
     Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
     Hemoglobin. 2022;46:347-350.
     PubMed     Abstract available
     
     
     
126. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
     Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
     Hemoglobin. 2022;46:297-302.
     PubMed     Abstract available
     
     
     
127. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
     Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
     Hemoglobin. 2022;46:308-311.
     PubMed     Abstract available
     
     
     
128. WU SM, Huang SR, Li C, Chen GL, et al
     Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
     Hemoglobin. 2022;46:341-343.
     PubMed     Abstract available
     
     
     
129. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
     Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
     Hemoglobin. 2022;46:317-324.
     PubMed     Abstract available
     
     
     
130. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
     Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
     Hemoglobin. 2022;46:303-307.
     PubMed     Abstract available
     
     
     
131. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
     A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
     Hemoglobin. 2022;46:338-340.
     PubMed     Abstract available
     
     
     
132. LONG J, Gong F, Sun L, Lai G, et al
     Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
     Hemoglobin. 2022;46:325-329.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.